Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)

China · Delayed Price · Currency is CNY

9.87

+0.15 (1.54%)

Sep 14, 2026, 3:00 PM CST

Market Cap	2.85B +54.7%
Revenue (ttm)	565.28M -6.8%
Net Income	-106.53M
EPS	-0.36
Shares Out	289.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,810,586
Open	9.66
Previous Close	9.72
Day's Range	9.50 - 9.93
52-Week Range	5.30 - 10.39
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About Jiangsu Nanfang Medical

Jiangsu Nanfang Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of transdermal products, medical adhesive tapes and bandages, sports protective equipment, first aid kits, nitrile gloves, and protective equipment in China and internationally. The company offers medical proof fabrics, care products, band-aids, and applications; medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic ... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1990

Employees 789

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603880

Full Company Profile

Financial Performance

In 2025, Jiangsu Nanfang Medical's revenue was 600.51 million, a decrease of -0.35% compared to the previous year's 602.62 million. Losses were -101.71 million, -46.66% less than in 2024.

Financial Statements